{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:47:41Z","timestamp":1778802461475,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.semarthrit.2011.11.008","type":"journal-article","created":{"date-parts":[[2012,1,4]],"date-time":"2012-01-04T23:44:55Z","timestamp":1325720695000},"page":"879-889","source":"Crossref","is-referenced-by-count":31,"title":["Use of Diuretics and the Risk of Gouty Arthritis: A Systematic Review"],"prefix":"10.1016","volume":"41","author":[{"given":"Berdine A.A.","family":"Hueskes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth A.","family":"Roovers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aukje K.","family":"Mantel-Teeuwisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein J.E.M.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloy H.","family":"van de Lisdonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthijs","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2011.11.008_bib1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1053\/j.ajkd.2008.07.035","article-title":"Management of hyperuricemia and gout in CKD","volume":"52","author":"Gaffo","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib2","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0140-6736(08)60799-0","article-title":"Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial","volume":"371","author":"Janssens","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib3","first-page":"S435","article-title":"Epidemiology of hyperuricemia and gout","volume":"11","author":"Luk","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib4","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.2007.076232","article-title":"Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005","volume":"67","author":"Annemans","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib6","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMcp030733","article-title":"Clinical practice","volume":"349","author":"Terkeltaub","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib7","doi-asserted-by":"crossref","first-page":"46S","DOI":"10.1016\/S0002-9343(97)89546-0","article-title":"Crystal-induced arthritis: an overview","volume":"100","author":"Schumacher","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib8","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2165\/00003495-200666120-00002","article-title":"Pathophysiology, clinical presentation and treatment of gout","volume":"66","author":"Teng","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10067-009-1362-1","article-title":"Clinical features of women with gout arthritis","volume":"29","author":"Jansen Dirken-Heukensfeldt","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout","volume":"143","author":"Choi","year":"2005","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.semarthrit.2011.11.008_bib11","doi-asserted-by":"crossref","first-page":"ii2","DOI":"10.1093\/rheumatology\/kep086","article-title":"New insights into the epidemiology of gout","volume":"48","author":"Doherty","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1023\/B:CARD.0000015855.02485.e3","article-title":"Cardiovascular drugs and serum uric acid","volume":"17","author":"Reyes","year":"2003","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib13","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/bjp.2008.343","article-title":"Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4","volume":"155","author":"El-Sheikh","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0002-9343(69)90187-9","article-title":"Factors affecting urate excretion following diuretic administration in man","volume":"47","author":"Steele","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib15","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?","volume":"41","author":"Johnson","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/gm118","article-title":"What lies behind serum urate concentration?","volume":"1","author":"Ichida","year":"2009","journal-title":"Genome Med"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1681\/ASN.2006040415","article-title":"Human renal organic anion transporter 4 operates as an asymmetric urate transporter","volume":"18","author":"Hagos","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib18","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/00004872-200311000-00002","article-title":"2003 World Health Organization (WHO)\/International Society of Hypertension (ISH) statement on management of hypertension","volume":"21","author":"Whitworth","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archinte.147.4.645","article-title":"Is thiazide-produced uric acid elevation harmful?","volume":"147","author":"Langford","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib21","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1001\/jama.1991.03470210072035","article-title":"Incidence and risk factors for gout in white men","volume":"266","author":"Roubenoff","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib22","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/ard.2005.049023","article-title":"Gout, diuretics and the kidney","volume":"65","author":"Pascual","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ncprheum0556","article-title":"The changing epidemiology of gout","volume":"3","author":"Roddy","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib24","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1001\/jama.289.21.2857","article-title":"Gout","volume":"289","author":"Rott","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/bmj.39449.819271.BE","article-title":"Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study","volume":"336","author":"Choi","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib27","series-title":"Ziekten in de huisartspraktijk","author":"Van de Lisdonk","year":"2008"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0895-4356(94)00097-A","article-title":"Best evidence synthesis: an intelligent alternative to meta-analysis","volume":"48","author":"Slavin","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib30","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0895-4356(97)00101-7","article-title":"Thiazide diuretics and the initiation of anti-gout therapy","volume":"50","author":"Gurwitz","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib31","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2009.123687","article-title":"Limited validity of the American College of Rheumatology criteria for classifying patients with gout in primary care","author":"Janssens","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib33","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib34","first-page":"539","article-title":"Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension","volume":"2","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib35","doi-asserted-by":"crossref","first-page":"50S","DOI":"10.1016\/0002-9343(91)90437-3","article-title":"The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial","volume":"90","author":"Staessen","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00004872-199103000-00005","article-title":"Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly","volume":"9","author":"Fletcher","year":"1991","journal-title":"J Hypertens"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0021-9681(76)90003-5","article-title":"Serum uric acid: its association with other risk factors and with mortality in coronary heart disease","volume":"29","year":"1976","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archinte.165.7.742","article-title":"Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study","volume":"165","author":"Choi","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9610(88)80196-X","article-title":"Hyperuricemia after renal transplantation","volume":"156","author":"Gores","year":"1988","journal-title":"Am J Surg"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.jhh.1000496","article-title":"Incidence of diabetes and gout in hypertensive patients during 8 years of follow-up","volume":"11","author":"Grodzicki","year":"1997","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib41","first-page":"1501","article-title":"The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study","volume":"27","author":"Lin","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib42","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3899\/jrheum.080768","article-title":"Gout in the elderly\u2014a population health study","volume":"36","author":"Hanly","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib43","first-page":"1341","article-title":"Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study","volume":"33","author":"Hunter","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib44","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/ard.2005.040360","article-title":"Gout, not induced by diuretics?","volume":"65","author":"Janssens","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1440-1797.2006.00577.x","article-title":"Gout in renal transplant recipients","volume":"11","author":"Stamp","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib46","first-page":"43","article-title":"High prevalence of gout in patients with Type 2 diabetes: male sex, renal impairment, and diuretic use are major risk factors","volume":"121","author":"Suppiah","year":"2008","journal-title":"N Z Med J"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/ard.51.2.259","article-title":"Diuretic induced gout: a multifactorial condition","volume":"51","author":"Scott","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.11.008_bib48","first-page":"457","article-title":"Predicting acute gout in diuretic-treated hypertensive patients","volume":"3","author":"Waller","year":"1989","journal-title":"J Hum Hypertens"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017211003581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017211003581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T08:50:02Z","timestamp":1543308602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017211003581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0049017211003581"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2011.11.008","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}